We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Solgenics Limited | LSE:SGN | London | Ordinary Share | VGG640631039 | ORD NPV (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.19 | 0.17 | 0.21 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMSGN
RNS Number : 6692R
Solgenics Limited
02 March 2023
News Release
Solgenics Limited (formerly Ncondezi Energy Limited)
Confirmation of Name Change - Replacement
The Confirmation of Name Change announcement released at 7.00am on 2 March 2023 (RNS 5920R) should have stated " Accordingly dealings under the new company name of Solgenics Limited and new TIDM "SGN", will commence from 8.00 a.m. on 2 March 2023" . All other details remain unchanged.
2 March 2023: Solgenics Limited ( the "Company") announces that, further to its announcement of 28 February 2023, the British Virgin Islands Financial Services Commission ("BVIFSC") has confirmed the name change from Ncondezi Energy Limited to Solgenics Limited ("Solgenics"). Accordingly dealings under the new company name of Solgenics Limited and new TIDM "SGN", will commence from 8.00 a.m. on 2 March 2023.
As previously announced, the name change Solgenics reflects the Company's focus on renewable energy development. The Company's ISIN will remain VGG640631039. The Company`s Legal Entity Identifier (LEI) remains 2138003W75PP9STE9J18. Shareholders should note that their shareholdings will be unaffected by the change of name. Existing share certificates should be retained as they will remain valid for all purposes and no new share certificates will be issued.
The information required to be disclosed pursuant to AIM Rule 26 of the AIM Rules for Companies can be accessed on https://www.ncondezienergy.com/aim-rule-26/ . The new website www.solgenics.com will go live on or around 6 March 2023 and the Company will make a further announcement to confirm this.
Commenting on the change of name, Hanno Pengilly, CEO said: "I am delighted to confirm the Company's change of name and we look forward to rebranding as Solgenics Limited. This provides a clear signal to all stakeholders that we are committed to developing clean, green power projects.
Offtake discussions for our flagship Tete Solar Project are progressing and we look forward to providing further updates later in the month."
E nqu iries
For further information please visit www.ncondezienergy.com or contact:
Solgenics: Hanno Pengilly +27 (0) 71 362 3566 Liberum Capital Limited: Scott Mathieson, Edward Thomas, NOMAD & Joint Broker Kane Collings +44 (0) 20 3100 2000 Novum Securities Limited Joint Broker Colin Rowbury +44 (0) 20 7399 9427 Pimlico Advisory Ltd +44 (0) 777 56 55 Investor Relations Elizabeth Johnson 927
About Solgenics
Solgenics (formerly Ncondezi Energy) is an African renewable energy development company focused on the development of a 300MW solar PV plus BESS renewable energy in the Tete Province in northern Mozambique (the "Tete Solar Project").
It is the intention that the Tete Solar Project will connect to the Mozambique grid with target power off takers
in Mozambique and the Southern African Power Pool ("SAPP").
The Tete Solar Project takes full advantage of Mozambique's leading sustainable energy resources and is fully
aligned with Government's objective to become a champion for energy transition impacting all Southern Africa.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
END
CANEANDAEEPDEEA
(END) Dow Jones Newswires
March 02, 2023 04:20 ET (09:20 GMT)
1 Year Solgenics Chart |
1 Month Solgenics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions